Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.
about
KASL clinical practice guidelines: management of chronic hepatitis BAntiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-AnalysisTDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China.Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patientsEfficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B.Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B PatientsImpact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patientsNephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in ThailandModeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction.Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiComparison of the efficacy of tenofovir monotherapy versus tenofovir-based combination therapy in adefovir-experienced chronic hepatitis B patients: a systematic review and meta-analysisTenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment.Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohortTenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice.Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures.Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy.A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
P2860
Q26752475-37977730-613D-4A82-AF6C-D4C3780A1F1EQ28074579-01169079-6B29-4386-B857-B6EE5FB04139Q33800724-A1D9CE5D-DDD1-46A1-85B6-DCB93AC70878Q35231822-FE6A0D88-76AC-485F-AB6A-60914F762209Q35671645-675A3454-0A78-4F3C-9F69-4A065D6B4E6EQ35677233-84E580D2-BB26-4EA3-A1F2-8497721F1A9DQ35824075-79F9B1DC-24EC-4AF3-9DA6-6841E089B73AQ35864595-655A4477-61FB-43A0-BAC1-6DF3B9662690Q36120901-D554225D-0078-4E5D-A9CC-7727F1C1EB31Q36235577-9DB23435-CBA6-4AAA-8274-BDE8EBE8624BQ36293979-E884666F-8A27-4D84-B4AD-65ABE9937FA8Q36492635-F5A2527A-312D-48E0-994F-610DDD1C496AQ36651312-0233BAD9-96AC-4F7F-9F22-F061FDCBB55AQ37229851-AE11CDE5-7198-4637-BAA1-ABF4A029F278Q37284974-EE01F47D-FC37-42A7-9D0E-602C29322D77Q37600575-494F3632-6F57-47B5-9F04-C1773236CE90Q37694907-A14E6F07-3E14-4C5F-9B15-9A6677233BF5Q37738814-DE92D900-D120-4BBE-B4F7-73A708CE3B22Q41367567-60176ED8-8AC3-4CF4-A95A-E04C76D737CEQ41645626-E37CB057-310D-4BB0-80BE-E0F616C3139AQ42151600-CB046ECB-ADC9-40A8-AB6E-4A2B7C4A1B13Q42153085-DBB74E98-9822-42DA-B76A-6667A7C02606Q42222328-65BAEEBC-B283-49F4-9603-DEF951AB86C1Q56669408-C0811048-910A-457E-86A6-6D4BF22DD2CF
P2860
Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Efficacy of tenofovir in patie ...... ents with chronic hepatitis B.
@ast
Efficacy of tenofovir in patie ...... ents with chronic hepatitis B.
@en
type
label
Efficacy of tenofovir in patie ...... ents with chronic hepatitis B.
@ast
Efficacy of tenofovir in patie ...... ents with chronic hepatitis B.
@en
prefLabel
Efficacy of tenofovir in patie ...... ents with chronic hepatitis B.
@ast
Efficacy of tenofovir in patie ...... ents with chronic hepatitis B.
@en
P2093
P2860
P356
P1476
Efficacy of tenofovir in patie ...... ients with chronic hepatitis B
@en
P2093
Asli Cifcibasi Ormeci
Cetin Karaca
Derya Onel
Fatih Besisik
Filiz Akyuz
Hamza Ugur Bozbey
Kadir Demir
Mine Gulluoglu
Ozlem Mutluay Soyer
Sabahattin Kaymakoglu
P2860
P304
P356
10.1128/AAC.02600-12
P407
P50
P577
2013-02-04T00:00:00Z